Development of clinical pathway for mild cognitive impairment and dementia to quantify cost of age-related cognitive disorders in Malaysia

Syed Mohamed Al-Junid Syed Junid, Namaitijiang Maimaiti, Zafar Ahmed, Amrizal Muhammad Nur, Norashidah Mohamed Nor, Normazwana Ismail, Sharifah Aizah Haron, Asrul Akmal Shafie, Mohmad Salleh, Suraya Yusuf, Zanariah Mat Saher, Ismail Drahman, Ahmad Rasidi M Saring, Nazariah Aiza Harun, Roshanim Koris

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

As the Malaysian population ages, the burden of age-related cognitive disorders such as dementia and Alzheimer's disease will increase concomitantly. This is one of the sub-study under a research project titled by quantify the cost of age-related cognitive impairment in Malaysia, which was undertaken to develop a clinical pathway for Mild Cognitive Impairment (MCI) and Dementia. The clinical pathway (CP) will be used to support the costing studies of MCI and Dementia. An expert group discussion (EGD) was conducted among selected experts from six (6) government hospitals from different states of Malaysia, Ministry of Health, and United Nations University, International Institute for Global Health, UKM and UPM. The expert group includes psychiatrist specialists and public health medicine specialists. A total of 15 participants took part in the EGD. The group was presented with the different approach in managing MCI and Dementia. Finally, the group came to the consensus agreement on the most appropriate and efficient ways of managing the two conditions. In the EGD, an operational definition for MCI and Dementia was agreed upon and a pathway was developed for the usual practice in the Malaysian health system. A typical case used, as a reference is a 60-year-old patient referred to a memory clinic with complaint of "forgetfulness". After three outpatient visits in the clinic, the diagnosis of MCI and Dementia could be clinically established. The clinical pathways covered all active clinical and non-clinical management of the patient over a period of one year. The experts identified the additional resources required to manage these patients for the whole spectrum of lifetime based on the expected life expectancy. The Clinical pathway (CP) for MCI and Dementia was successfully developed in EGD with strong support from practitioners in the health system. The findings will help the researchers to identify all-important clinical activities and interventions that will be included in the costing study.

Original languageEnglish
Pages (from-to)88-96
Number of pages9
JournalMalaysian Journal of Public Health Medicine
Volume14
Issue number3
Publication statusPublished - 2014

Fingerprint

Critical Pathways
Malaysia
Dementia
Costs and Cost Analysis
Health
State Hospitals
United Nations
Ambulatory Care
Life Expectancy
Cognitive Dysfunction
Psychiatry
Consensus
Alzheimer Disease
Outpatients
Public Health
Research Personnel
Medicine
Research
Population

Keywords

  • Clinical pathway
  • Cost
  • Dementia
  • Malaysia
  • Mild cognitive impairment

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Development of clinical pathway for mild cognitive impairment and dementia to quantify cost of age-related cognitive disorders in Malaysia. / Syed Junid, Syed Mohamed Al-Junid; Maimaiti, Namaitijiang; Ahmed, Zafar; Nur, Amrizal Muhammad; Nor, Norashidah Mohamed; Ismail, Normazwana; Haron, Sharifah Aizah; Shafie, Asrul Akmal; Salleh, Mohmad; Yusuf, Suraya; Saher, Zanariah Mat; Drahman, Ismail; Saring, Ahmad Rasidi M; Harun, Nazariah Aiza; Koris, Roshanim.

In: Malaysian Journal of Public Health Medicine, Vol. 14, No. 3, 2014, p. 88-96.

Research output: Contribution to journalArticle

Syed Junid, SMA-J, Maimaiti, N, Ahmed, Z, Nur, AM, Nor, NM, Ismail, N, Haron, SA, Shafie, AA, Salleh, M, Yusuf, S, Saher, ZM, Drahman, I, Saring, ARM, Harun, NA & Koris, R 2014, 'Development of clinical pathway for mild cognitive impairment and dementia to quantify cost of age-related cognitive disorders in Malaysia', Malaysian Journal of Public Health Medicine, vol. 14, no. 3, pp. 88-96.
Syed Junid, Syed Mohamed Al-Junid ; Maimaiti, Namaitijiang ; Ahmed, Zafar ; Nur, Amrizal Muhammad ; Nor, Norashidah Mohamed ; Ismail, Normazwana ; Haron, Sharifah Aizah ; Shafie, Asrul Akmal ; Salleh, Mohmad ; Yusuf, Suraya ; Saher, Zanariah Mat ; Drahman, Ismail ; Saring, Ahmad Rasidi M ; Harun, Nazariah Aiza ; Koris, Roshanim. / Development of clinical pathway for mild cognitive impairment and dementia to quantify cost of age-related cognitive disorders in Malaysia. In: Malaysian Journal of Public Health Medicine. 2014 ; Vol. 14, No. 3. pp. 88-96.
@article{deed49cc5e0e45d39ac36539cf87d3ce,
title = "Development of clinical pathway for mild cognitive impairment and dementia to quantify cost of age-related cognitive disorders in Malaysia",
abstract = "As the Malaysian population ages, the burden of age-related cognitive disorders such as dementia and Alzheimer's disease will increase concomitantly. This is one of the sub-study under a research project titled by quantify the cost of age-related cognitive impairment in Malaysia, which was undertaken to develop a clinical pathway for Mild Cognitive Impairment (MCI) and Dementia. The clinical pathway (CP) will be used to support the costing studies of MCI and Dementia. An expert group discussion (EGD) was conducted among selected experts from six (6) government hospitals from different states of Malaysia, Ministry of Health, and United Nations University, International Institute for Global Health, UKM and UPM. The expert group includes psychiatrist specialists and public health medicine specialists. A total of 15 participants took part in the EGD. The group was presented with the different approach in managing MCI and Dementia. Finally, the group came to the consensus agreement on the most appropriate and efficient ways of managing the two conditions. In the EGD, an operational definition for MCI and Dementia was agreed upon and a pathway was developed for the usual practice in the Malaysian health system. A typical case used, as a reference is a 60-year-old patient referred to a memory clinic with complaint of {"}forgetfulness{"}. After three outpatient visits in the clinic, the diagnosis of MCI and Dementia could be clinically established. The clinical pathways covered all active clinical and non-clinical management of the patient over a period of one year. The experts identified the additional resources required to manage these patients for the whole spectrum of lifetime based on the expected life expectancy. The Clinical pathway (CP) for MCI and Dementia was successfully developed in EGD with strong support from practitioners in the health system. The findings will help the researchers to identify all-important clinical activities and interventions that will be included in the costing study.",
keywords = "Clinical pathway, Cost, Dementia, Malaysia, Mild cognitive impairment",
author = "{Syed Junid}, {Syed Mohamed Al-Junid} and Namaitijiang Maimaiti and Zafar Ahmed and Nur, {Amrizal Muhammad} and Nor, {Norashidah Mohamed} and Normazwana Ismail and Haron, {Sharifah Aizah} and Shafie, {Asrul Akmal} and Mohmad Salleh and Suraya Yusuf and Saher, {Zanariah Mat} and Ismail Drahman and Saring, {Ahmad Rasidi M} and Harun, {Nazariah Aiza} and Roshanim Koris",
year = "2014",
language = "English",
volume = "14",
pages = "88--96",
journal = "Malaysian Journal of Public Health Medicine",
issn = "1675-0306",
publisher = "Malaysian Public Health Physicians' Association",
number = "3",

}

TY - JOUR

T1 - Development of clinical pathway for mild cognitive impairment and dementia to quantify cost of age-related cognitive disorders in Malaysia

AU - Syed Junid, Syed Mohamed Al-Junid

AU - Maimaiti, Namaitijiang

AU - Ahmed, Zafar

AU - Nur, Amrizal Muhammad

AU - Nor, Norashidah Mohamed

AU - Ismail, Normazwana

AU - Haron, Sharifah Aizah

AU - Shafie, Asrul Akmal

AU - Salleh, Mohmad

AU - Yusuf, Suraya

AU - Saher, Zanariah Mat

AU - Drahman, Ismail

AU - Saring, Ahmad Rasidi M

AU - Harun, Nazariah Aiza

AU - Koris, Roshanim

PY - 2014

Y1 - 2014

N2 - As the Malaysian population ages, the burden of age-related cognitive disorders such as dementia and Alzheimer's disease will increase concomitantly. This is one of the sub-study under a research project titled by quantify the cost of age-related cognitive impairment in Malaysia, which was undertaken to develop a clinical pathway for Mild Cognitive Impairment (MCI) and Dementia. The clinical pathway (CP) will be used to support the costing studies of MCI and Dementia. An expert group discussion (EGD) was conducted among selected experts from six (6) government hospitals from different states of Malaysia, Ministry of Health, and United Nations University, International Institute for Global Health, UKM and UPM. The expert group includes psychiatrist specialists and public health medicine specialists. A total of 15 participants took part in the EGD. The group was presented with the different approach in managing MCI and Dementia. Finally, the group came to the consensus agreement on the most appropriate and efficient ways of managing the two conditions. In the EGD, an operational definition for MCI and Dementia was agreed upon and a pathway was developed for the usual practice in the Malaysian health system. A typical case used, as a reference is a 60-year-old patient referred to a memory clinic with complaint of "forgetfulness". After three outpatient visits in the clinic, the diagnosis of MCI and Dementia could be clinically established. The clinical pathways covered all active clinical and non-clinical management of the patient over a period of one year. The experts identified the additional resources required to manage these patients for the whole spectrum of lifetime based on the expected life expectancy. The Clinical pathway (CP) for MCI and Dementia was successfully developed in EGD with strong support from practitioners in the health system. The findings will help the researchers to identify all-important clinical activities and interventions that will be included in the costing study.

AB - As the Malaysian population ages, the burden of age-related cognitive disorders such as dementia and Alzheimer's disease will increase concomitantly. This is one of the sub-study under a research project titled by quantify the cost of age-related cognitive impairment in Malaysia, which was undertaken to develop a clinical pathway for Mild Cognitive Impairment (MCI) and Dementia. The clinical pathway (CP) will be used to support the costing studies of MCI and Dementia. An expert group discussion (EGD) was conducted among selected experts from six (6) government hospitals from different states of Malaysia, Ministry of Health, and United Nations University, International Institute for Global Health, UKM and UPM. The expert group includes psychiatrist specialists and public health medicine specialists. A total of 15 participants took part in the EGD. The group was presented with the different approach in managing MCI and Dementia. Finally, the group came to the consensus agreement on the most appropriate and efficient ways of managing the two conditions. In the EGD, an operational definition for MCI and Dementia was agreed upon and a pathway was developed for the usual practice in the Malaysian health system. A typical case used, as a reference is a 60-year-old patient referred to a memory clinic with complaint of "forgetfulness". After three outpatient visits in the clinic, the diagnosis of MCI and Dementia could be clinically established. The clinical pathways covered all active clinical and non-clinical management of the patient over a period of one year. The experts identified the additional resources required to manage these patients for the whole spectrum of lifetime based on the expected life expectancy. The Clinical pathway (CP) for MCI and Dementia was successfully developed in EGD with strong support from practitioners in the health system. The findings will help the researchers to identify all-important clinical activities and interventions that will be included in the costing study.

KW - Clinical pathway

KW - Cost

KW - Dementia

KW - Malaysia

KW - Mild cognitive impairment

UR - http://www.scopus.com/inward/record.url?scp=84940208307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940208307&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84940208307

VL - 14

SP - 88

EP - 96

JO - Malaysian Journal of Public Health Medicine

JF - Malaysian Journal of Public Health Medicine

SN - 1675-0306

IS - 3

ER -